Logo (Pamidronate 01)
Pamidronate Disodium Injection, Solution
Product Images NDC 61703-326
10 FDA label images from Hospira, Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Pamidronate Disodium (NDC 61703-326). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Structural Formula Pamidronate Disodium (Pamidronate 01a)
Chemical structure of pamidronate disodium, showing its molecular arrangement with amino, carbon, hydroxyl, and phosphate groups.*
Figure 1: Pamidronate Renal Clearance As A Function Of Creatinine Clearance In Patients With Normal And Impaired Renal Function. (Pamidronate 02)
A scatter plot graph titled 'Pamidronate Renal CL vs CLcr' showing renal clearance (mL/min) on the y-axis against creatinine clearance (CLcr) (mL/min) on the x-axis. The plot includes observed data points and lines for predicted values with corresponding upper and lower 95% confidence intervals.*
Logo (Pamidronate 03)
Principal Display Panel (60 mg/10 mL Vial Label)
Pamidronate Disodium Injection 60 mg/10 mL (6 mg/mL) sterile intravenous solution vial label. The 10 mL vial is for prescription use only and includes storage instructions, ingredients, and distribution information by Hospira, Inc., Lake Forest, IL.*
Principal Display Panel (60 mg/10 mL Vial Carton)
Pamidronate Disodium Injection 60 mg per 10 mL (6 mg/mL), intravenous solution in a single-use vial. The label shows the product is distributed by Hospira, Inc. and made in Argentina. It includes storage instructions and a warning not to mix with calcium-containing infusion solutions.*
Principal Display Panel (90 mg/10 mL Vial Label)
Pamidronate Disodium Injection 90 mg per 10 mL (9 mg/mL) in a 10 mL sterile vial. The label states it is for intravenous infusion and warns not to mix with calcium-containing infusion solutions. Distributed by Hospira, Inc., Lake Forest, IL, USA. NDC 61703-326-18 is shown.*
Principal Display Panel (90 mg/10 mL Vial Carton)
Pamidronate Disodium Injection 90 mg/10 mL (9 mg/mL) vial packaging label from Hospira, Inc. The label includes instructions for storage at 20 to 25°C, cautions against mixing with calcium-containing infusion solutions, and indicates the product is for intravenous infusion as a single-use vial. It also lists ingredients and provides manufacturer and distribution information, showing the vial size as 10 mL sterile solution.*
Principal Display Panel (30 mg/10 mL Vial Label)
Label for Pamidronate Disodium Injection 30 mg/10 mL (3 mg/mL) in a 10 mL sterile vial. The label states it is for intravenous infusion and should not be mixed with calcium-containing infusion solutions. It includes manufacturer and distributor information for Hospira, Inc., Lake Forest, IL, USA, along with handling and storage instructions.*
Principal Display Panel (30 mg/10 mL Vial Carton)
Pamidronate Disodium Injection 30 mg/10 mL (3 mg/mL) solution in a single-use vial carton. The label states it is sterile, for intravenous infusion, and distributed by Hospira, Inc. It includes storage instructions and notes the solution contains Pamidronate Disodium 30 mg and mannitol USP 470 mg per 10 mL. The product is made in Argentina.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
